bioMérieux Stock Euronext Paris
Stocks
FR0010096479
Medical Equipment, Supplies & Distribution
OTC Markets Traded| Market Cap | 8.57B 9.9B 8.01B 7.32B 13.8B 945B 14.02B 93.98B 36.88B 473B 37.19B 36.38B 1,574B | P/E 2026 * |
17.8x | P/E 2027 * | 16.2x |
|---|---|---|---|---|---|
| Enterprise Value | 8.17B 9.43B 7.63B 6.98B 13.15B 900B 13.35B 89.51B 35.12B 450B 35.42B 34.65B 1,499B | EV / Sales 2026 * |
1.98x | EV / Sales 2027 * | 1.81x |
| Free-Float |
33.22% | Yield 2026 * |
1.43% | Yield 2027 * | 1.59% |
Last Transcript: bioMérieux
| 1 day | -0.27% |
| Manager | Title | Age | Since |
|---|---|---|---|
Pierre Boulud
CEO | Chief Executive Officer | 53 | 01/07/2023 |
| Director of Finance/CFO | 50 | 01/03/2018 | |
| Chief Tech/Sci/R&D Officer | - | 01/08/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 51 | 15/12/2017 | |
| Director/Board Member | 66 | 01/01/2005 | |
| Director/Board Member | 61 | 30/05/2012 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.27% | +1.25% | - | - | 9.91B | |
| +0.64% | +6.40% | +208.39% | +368.39% | 22.61B | |
| +0.62% | +1.45% | -41.17% | -22.92% | 9.91B | |
| +9.98% | +19.32% | +355.68% | +8.06% | 6.78B | |
| -0.01% | -0.32% | +79.90% | +48.14% | 6.59B | |
| +1.01% | +40.62% | -24.03% | - | 6.43B | |
| +1.51% | +2.40% | -10.99% | -11.55% | 5.62B | |
| -0.47% | +5.58% | +82.30% | +102.41% | 4.51B | |
| +1.17% | +1.49% | -7.52% | -19.60% | 4.31B | |
| +1.30% | -0.79% | -19.78% | -35.40% | 2.75B | |
| Average | +1.57% | +8.97% | +69.20% | +54.69% | 7.72B | |
| Weighted average by Cap. | +1.33% | +8.43% | +105.15% | +137.74% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.12B 4.76B 3.85B 3.52B 6.64B 454B 6.74B 45.21B 17.74B 227B 17.89B 17.5B 757B | 4.34B 5.01B 4.05B 3.71B 6.98B 478B 7.09B 47.54B 18.66B 239B 18.81B 18.4B 796B |
| Net income | 482M 557M 451M 412M 777M 53.14B 789M 5.29B 2.07B 26.59B 2.09B 2.05B 88.55B | 525M 607M 491M 449M 846M 57.87B 859M 5.76B 2.26B 28.95B 2.28B 2.23B 96.43B |
| Net Debt | -408M -471M -381M -348M -656M -44.91B -667M -4.47B -1.75B -22.47B -1.77B -1.73B -74.83B | -731M -845M -683M -625M -1.18B -80.56B -1.2B -8.01B -3.14B -40.3B -3.17B -3.1B -134B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
